Nektar Therapeutics Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 08/13/2026 | 5.07 M | $353.79 M | 17.77% | 15.33% |
| TWO SEAS CAPITAL LP | 08/12/2026 | 3.09 M | $215.87 M | 57.83% | 9.35% |
| BLACKROCK, INC. | 08/07/2026 | 2.94 M | $205.37 M | 324.72% | 8.90% |
| BVF INC/IL | 08/14/2026 | 2.39 M | $166.92 M | -6.58% | 7.23% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 1.50 M | $104.50 M | 25.04% | 4.53% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 1.20 M | $83.91 M | 29.14% | 3.64% |
| VESTAL POINT CAPITAL, LP | 08/14/2026 | 1.00 M | $69.81 M | 250.88% | 3.03% |
| MORGAN STANLEY | 08/13/2026 | 936.56 K | $65.38 M | 42.04% | 2.83% |
| STATE STREET CORP | 08/07/2026 | 909.68 K | $63.50 M | 271.71% | 2.75% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 881.31 K | $61.54 M | 154.13% | 2.67% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 823.70 K | $57.50 M | 90.23% | 2.49% |
| PROSIGHT MANAGEMENT, LP | 08/14/2026 | 810.00 K | $56.55 M | 10.20% | 2.45% |
| ARMISTICE CAPITAL, LLC | 08/14/2026 | 724.00 K | $50.54 M | 25.26% | 2.19% |
| GILDER GAGNON HOWE & CO LLC | 08/14/2026 | 600.87 K | $41.95 M | 121.11% | 1.82% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 478.12 K | $33.38 M | 18.27% | 1.45% |
| BRAIDWELL LP | 08/14/2026 | 473.62 K | $33.06 M | 112.67% | 1.43% |
| SOFINNOVA INVESTMENTS, INC. | 08/14/2026 | 471.76 K | $32.93 M | -7.42% | 1.43% |
| WOODLINE PARTNERS LP | 08/14/2026 | 470.88 K | $32.87 M | 13.37% | 1.42% |
| ORBIMED ADVISORS LLC | 08/14/2026 | 465.35 K | $32.49 M | 69.22% | 1.41% |
| UBS GROUP AG | 08/13/2026 | 428.40 K | $29.91 M | 33.80% | 1.30% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 394.50 K | $27.54 M | 78.43% | 1.19% |
| EMERALD ADVISERS, LLC | 08/05/2026 | 390.16 K | $27.24 M | -1.13% | 1.18% |
| LORD, ABBETT & CO. LLC | 08/14/2026 | 381.62 K | $26.64 M | -5.79% | 1.15% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 348.54 K | $24.33 M | 380.80% | 1.05% |
| DAFNA CAPITAL MANAGEMENT LLC | 08/14/2026 | 318.38 K | $22.23 M | 92.75% | 0.96% |
| NORTHERN TRUST CORP | 08/13/2026 | 308.53 K | $21.54 M | 292.54% | 0.93% |
| DEEP TRACK CAPITAL, LP | 08/14/2026 | 300.00 K | $20.94 M | 100.00% | 0.91% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 284.97 K | $19.89 M | 69.62% | 0.86% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 284.97 K | $19.89 M | 100.00% | 0.86% |
| 22NW, LP | 08/14/2026 | 281.12 K | $19.62 M | 0.00% | 0.85% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 278.98 K | $19.48 M | 12.00% | 0.84% |
| PRIMECAP MANAGEMENT CO/CA/ | 08/14/2026 | 272.85 K | $19.05 M | -2.26% | 0.83% |
| BARCLAYS PLC | 08/14/2026 | 262.36 K | $18.32 M | 710.86% | 0.79% |
| NEARWATER CAPITAL MARKETS, LTD | 08/14/2026 | 261.50 K | $18.26 M | 0.00% | 0.79% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 08/05/2026 | 255.59 K | $17.84 M | -0.20% | 0.77% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 244.18 K | $17.05 M | 51.43% | 0.74% |
| CREEK DRIVE MANAGEMENT GROUP LLC | 08/13/2026 | 243.00 K | $16.96 M | 92.25% | 0.74% |
| SEVEN GRAND MANAGERS, LLC | 08/14/2026 | 240.00 K | $16.75 M | 92.00% | 0.73% |
| DEUTSCHE BANK AG\ | 08/07/2026 | 239.83 K | $16.74 M | 161.62% | 0.73% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 239.58 K | $16.72 M | 41.50% | 0.72% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 228.49 K | $15.95 M | 80.00% | 0.69% |
| NORGES BANK | 08/12/2026 | 215.30 K | $15.03 M | 100.00% | 0.65% |
| BRONTE CAPITAL MANAGEMENT PTY LTD. | 08/05/2026 | 198.43 K | $13.85 M | 0.09% | 0.60% |
| CITADEL ADVISORS LLC | 09/02/2026 | 175.50 K | $12.25 M | 355.84% | 0.53% |
| GREAT POINT PARTNERS LLC | 08/14/2026 | 175.00 K | $12.22 M | -44.70% | 0.53% |
| CAPTION MANAGEMENT, LLC | 08/14/2026 | 171.10 K | $11.94 M | 62.95% | 0.52% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 170.00 K | $11.87 M | 100.00% | 0.51% |
| AMERIPRISE FINANCIAL INC | 08/14/2026 | 165.94 K | $11.58 M | 21.36% | 0.50% |
| CITADEL ADVISORS LLC | 09/02/2026 | 163.80 K | $11.43 M | 44.44% | 0.50% |
| CITADEL ADVISORS LLC | 09/02/2026 | 159.75 K | $11.15 M | -68.89% | 0.48% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Nektar Therapeutics institutional Ownership - FAQ's
During the previous two years, 407 institutional investors and hedge funds held shares of Nektar Therapeutics. The most heavily invested institutionals were:
FMR LLC: 5.07 M
Two Seas Capital LP: 3.09 M
BlackRock, Inc.: 2.94 M
BVF INC/IL: 2.39 M
VANGUARD CAPITAL MANAGEMENT LLC: 1.5 M
TWO SIGMA INVESTMENTS, LP: 1.2 M
109.38% of Nektar Therapeutics stock is owned by institutional investors.
Institutional investors have bought a total of 101.02 M shares in the last 24 months. This purchase volume represents approximately $6.99 B in transactions.